{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:09:30Z","timestamp":1787501370574,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670166"],"award-info":[{"award-number":["81670166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81230013"],"award-info":[{"award-number":["81230013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530046"],"award-info":[{"award-number":["81530046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670167"],"award-info":[{"award-number":["81670167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41409-019-0509-1","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T06:04:22Z","timestamp":1553234662000},"page":"1694-1700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"54","author":[{"given":"Zheng-Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"509_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol. 2018;11:33. \n                    https:\/\/doi.org\/10.1186\/s13045-018-0564-x\n                    \n                  .","journal-title":"J Hematol Oncol"},{"key":"509_CR2","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol: Off J Am Soc Clin Oncol. 1988;6:1562\u20138.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"509_CR3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","volume":"68","author":"MA Goldberg","year":"1986","unstructured":"Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986;68:1114\u20138.","journal-title":"Blood"},{"key":"509_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.bmt.1704487","volume":"33","author":"M Sakata-Yanagimoto","year":"2004","unstructured":"Sakata-Yanagimoto M, Kanda Y, Nakagawa M, Asano-Mori Y, Kandabashi K, Izutsu K, et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:1043\u20137. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704487\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","volume":"28","author":"T Murdych","year":"2001","unstructured":"Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant. 2001;28:283\u20137. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1703133\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1200\/jco.1994.12.5.998","volume":"12","author":"B Hertenstein","year":"1994","unstructured":"Hertenstein B, Stefanic M, Schmeiser T, Scholz M, Goller V, Clausen M, et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol. 1994;12:998\u20131004. \n                    https:\/\/doi.org\/10.1200\/jco.1994.12.5.998\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"509_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.bmt.1703890","volume":"31","author":"M Akahori","year":"2003","unstructured":"Akahori M, Nakamae H, Hino M, Yamane T, Hayashi T, Ohta K, et al. Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue. Bone Marrow Transplant. 2003;31:585\u201390. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1703890\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR8","doi-asserted-by":"publisher","unstructured":"Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016;175:265\u201374. \n                    https:\/\/doi.org\/10.1111\/bjh.14225","DOI":"10.1111\/bjh.14225"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25. \n                    https:\/\/doi.org\/10.1186\/s13045-017-0398-y\n                    \n                  .","journal-title":"J Hematol Oncol"},{"key":"509_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","volume":"95","author":"S Ishida","year":"2016","unstructured":"Ishida S, Doki N, Shingai N, Yoshioka K, Kakihana K, Sakamaki H, et al. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ann Hematol. 2016;95:1145\u201350. \n                    https:\/\/doi.org\/10.1007\/s00277-016-2654-6\n                    \n                  .","journal-title":"Ann Hematol"},{"key":"509_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.20042","volume":"76","author":"H Nakamae","year":"2004","unstructured":"Nakamae H, Hino M, Akahori M, Terada Y, Yamane T, Ohta K, et al. Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2004;76:1\u20137. \n                    https:\/\/doi.org\/10.1002\/ajh.20042\n                    \n                  .","journal-title":"Am J Hematol"},{"key":"509_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","volume":"27","author":"K Fujimaki","year":"2001","unstructured":"Fujimaki K, Maruta A, Yoshida M, Sakai R, Tanabe J, Koharazawa H, et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant. 2001;27:307\u201310. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1702783\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.transproceed.2007.11.077","volume":"40","author":"GT Sucak","year":"2008","unstructured":"Sucak GT, Ozkurt ZN, Aki Z, Yagci M, Cengel A, Haznedar R. Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity. Transplant Proc. 2008;40:1586\u201390. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2007.11.077\n                    \n                  .","journal-title":"Transplant Proc"},{"key":"509_CR14","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","volume":"118","author":"SH Armenian","year":"2011","unstructured":"Armenian SH, Sun CL, Shannon T, Mills G, Francisco L, Venkataraman K, et al. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood. 2011;118:6023\u20139. \n                    https:\/\/doi.org\/10.1182\/blood-2011-06-358226\n                    \n                  .","journal-title":"Blood"},{"key":"509_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00277-013-1682-8","volume":"92","author":"S Sivgin","year":"2013","unstructured":"Sivgin S, Eser B. The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: where do we stand? Ann Hematol. 2013;92:577\u201386. \n                    https:\/\/doi.org\/10.1007\/s00277-013-1682-8\n                    \n                  .","journal-title":"Ann Hematol"},{"key":"509_CR16","first-page":"173","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Petersen FB, Schor RA, Denney JD, Fisher LD, Appelbaum FR, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant. 1990;5:173\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"509_CR17","first-page":"219","volume":"50","author":"EJ Freireich","year":"1966","unstructured":"Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966;50:219\u201344.","journal-title":"Cancer Chemother Rep"},{"key":"509_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1200\/jco.1991.9.7.1215","volume":"9","author":"AC Braverman","year":"1991","unstructured":"Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9:1215\u201323. \n                    https:\/\/doi.org\/10.1200\/jco.1991.9.7.1215\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"509_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1083-8791(99)70008-X","volume":"5","author":"A Alidina","year":"1999","unstructured":"Alidina A, Lawrence D, Ford LA, Baer MR, Bambach B, Bernstein SH, et al. Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors. Biol Blood Marrow Transplant. 1999;5:322\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"509_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sj.bmt.1702466","volume":"26","author":"S Lehmann","year":"2000","unstructured":"Lehmann S, Isberg B, Ljungman P, Paul C. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2000;26:187\u201392. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1702466\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s0140-6736(00)02051-1","volume":"355","author":"H Nakamae","year":"2000","unstructured":"Nakamae H, Tsumura K, Hino M, Hayashi T, Tatsumi N. QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide. Lancet (Lond, Engl). 2000;355:805\u20136. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(00)02051-1\n                    \n                  .","journal-title":"Lancet (Lond, Engl)"},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","volume":"35","author":"P Morandi","year":"2005","unstructured":"Morandi P, Ruffini PA, Benvenuto GM, Raimondi R, Fosser V. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant. 2005;35:323\u201334. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704763\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"509_CR23","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41409-018-0155-z","volume":"53","author":"CN Duncan","year":"2018","unstructured":"Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, et al. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53:1278\u201387. \n                    https:\/\/doi.org\/10.1038\/s41409-018-0155-z","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0509-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:14:25Z","timestamp":1684602865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0509-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}